Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania

The World Health Organization recommends artemisinin-based combination (ACT) for the treatment of uncomplicated malaria. Post-licensure safety data on newly registered ACT is critical for evaluating their risk/benefit profile in malaria endemic countries. The clinical safety of the newly registered...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Malaria journal 2015-04, Vol.14 (1), p.160, Article 160
Hauptverfasser:	Baiden, Rita, Oduro, Abraham, Halidou, Tinto, Gyapong, Margaret, Sie, Ali, Macete, Eusebio, Abdulla, Salim, Owusu-Agyei, Seth, Mulokozi, Abdunoor, Adjei, Alex, Sevene, Esperanca, Compaoré, Guillaume, Valea, Innocent, Osei, Isaac, Yawson, Abena, Adjuik, Martin, Akparibo, Raymond, Ogutu, Bernhards, Upunda, Gabriel Leonard, Smith, Peter, Binka, Fred
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Africa Aged Aged, 80 and over Antimalarials - administration & dosage Antimalarials - adverse effects Artemisinins - administration & dosage Artemisinins - adverse effects Care and treatment Child Child, Preschool Cohort Studies Comparative analysis Control Drug Combinations Drug therapy Drug-Related Side Effects and Adverse Reactions - epidemiology Drug-Related Side Effects and Adverse Reactions - pathology Female Gastrointestinal diseases Health aspects Health Facilities Heart Conduction System - drug effects Humans Infant Infant, Newborn Longitudinal Studies Malaria Malaria - drug therapy Male Medical research Medicine, Experimental Middle Aged Prospective Studies Quinolines - administration & dosage Quinolines - adverse effects Safety and security measures Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!